Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.845
-0.035 (-1.86%)
Nov 21, 2024, 11:58 AM EST - Market open
Virax Biolabs Group Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Cash & Equivalents | 3.59 | 3.59 | 9.35 | 0.02 | 0.02 | 0.02 |
| Short-Term Investments | 0.08 | 0.08 | 0.05 | 0.01 | - | - |
| Cash & Short-Term Investments | 3.67 | 3.67 | 9.4 | 0.03 | 0.02 | 0.02 |
| Cash Growth | -61.00% | -61.00% | 33774.24% | 57.51% | -22.06% | - |
| Accounts Receivable | - | - | - | - | 0 | - |
| Other Receivables | 0.22 | 0.22 | - | - | - | - |
| Receivables | 0.22 | 0.22 | - | - | 0 | - |
| Inventory | 0.31 | 0.31 | 0.02 | 0.02 | 0.02 | - |
| Prepaid Expenses | 0.19 | 0.19 | 0.21 | - | - | - |
| Total Current Assets | 4.38 | 4.38 | 9.63 | 0.05 | 0.04 | 0.02 |
| Property, Plant & Equipment | 1.05 | 1.05 | - | - | - | - |
| Other Intangible Assets | 0.05 | 0.05 | 0.18 | - | - | - |
| Total Assets | 5.48 | 5.48 | 9.81 | 0.05 | 0.04 | 0.02 |
| Accounts Payable | 0.05 | 0.05 | 0.16 | 0.85 | 0.22 | 0.21 |
| Accrued Expenses | 0.08 | 0.08 | 0.55 | 0.4 | 0.46 | 0.25 |
| Short-Term Debt | - | - | 0.16 | - | 0.18 | 0.76 |
| Current Portion of Leases | 0.05 | 0.05 | - | - | - | - |
| Current Unearned Revenue | - | - | 0.04 | - | - | - |
| Other Current Liabilities | - | - | - | 0 | 0.02 | 0.02 |
| Total Current Liabilities | 0.17 | 0.17 | 0.91 | 1.25 | 0.87 | 1.24 |
| Long-Term Leases | 0.18 | 0.18 | - | - | - | - |
| Total Liabilities | 0.35 | 0.35 | 0.91 | 1.25 | 0.87 | 1.24 |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -18.53 | -18.53 | -11.79 | -6.34 | -4.63 | -3.98 |
| Comprehensive Income & Other | 23.89 | 23.89 | 20.92 | 5.36 | 3.98 | 2.92 |
| Total Common Equity | 5.37 | 5.37 | 9.13 | -0.97 | -0.65 | -1.06 |
| Minority Interest | -0.23 | -0.23 | -0.22 | -0.22 | -0.18 | -0.16 |
| Shareholders' Equity | 5.14 | 5.14 | 8.9 | -1.2 | -0.83 | -1.22 |
| Total Liabilities & Equity | 5.48 | 5.48 | 9.81 | 0.05 | 0.04 | 0.02 |
| Total Debt | 0.22 | 0.22 | 0.16 | - | 0.18 | 0.76 |
| Net Cash (Debt) | 3.44 | 3.44 | 9.24 | 0.03 | -0.16 | -0.73 |
| Net Cash Growth | -62.73% | -62.73% | 33181.39% | - | - | - |
| Net Cash Per Share | 1.72 | 1.72 | 8.69 | 0.03 | -0.66 | -7.02 |
| Filing Date Shares Outstanding | 2.57 | 2.57 | 1.79 | 1 | 1 | 0.1 |
| Total Common Shares Outstanding | 2.57 | 2.57 | 1.55 | 1 | 0.92 | 0.1 |
| Working Capital | 4.21 | 4.21 | 8.73 | -1.2 | -0.83 | -1.22 |
| Book Value Per Share | 2.09 | 2.09 | 5.87 | -0.98 | -0.70 | -10.12 |
| Tangible Book Value | 5.32 | 5.32 | 8.95 | -0.97 | -0.65 | -1.06 |
| Tangible Book Value Per Share | 2.07 | 2.07 | 5.76 | -0.98 | -0.70 | -10.12 |
| Machinery | 0.9 | 0.9 | 0.01 | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.